Satoshi Yoshiji

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Identifying circulating protein targets for common factors underlying schizophrenia, depression, and bipolar disorder.

Identifying circulating protein targets for common factors underlying schizophrenia, depression, and bipolar disorder.

Journal: medRxiv : the preprint server for health sciences

Published: June 12, 2026

Triangulating Evidence in Proteome-Wide Mendelian Randomization for Cardiovascular Disease: Insights Across Ancestries and Modalities.

Triangulating Evidence in Proteome-Wide Mendelian Randomization for Cardiovascular Disease: Insights Across Ancestries and Modalities.

Journal: Journal of the American College of Cardiology

Published: May 18, 2026

Cardiovascular Efficacy of GLP-1 Receptor Agonists by Kidney Function: An Updated Meta-Analysis of Randomized Trials Including the SOUL Trial.

Cardiovascular Efficacy of GLP-1 Receptor Agonists by Kidney Function: An Updated Meta-Analysis of Randomized Trials Including the SOUL Trial.

Journal: Diabetes, obesity & metabolism

Published: May 11, 2026

Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors in chronic kidney disease: an updated meta-analysis.

Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors in chronic kidney disease: an updated meta-analysis.

Journal: Journal of nephrology

Published: May 09, 2026

Phenome-Wide Mendelian Randomization Identifying Circulating Proteins for Cardiovascular Traits in Populations of African Ancestry.

Phenome-Wide Mendelian Randomization Identifying Circulating Proteins for Cardiovascular Traits in Populations of African Ancestry.

Journal: Circulation. Genomic and precision medicine

Published: February 09, 2026

Estimated Glomerular Filtration Rate Change and Heart Failure Events With GLP-1 Receptor Agonists: A Meta-Analysis and Meta-Regression of Randomised Controlled Trials.

Estimated Glomerular Filtration Rate Change and Heart Failure Events With GLP-1 Receptor Agonists: A Meta-Analysis and Meta-Regression of Randomised Controlled Trials.

Journal: Diabetes, obesity & metabolism

Published: February 08, 2026

A resource of "bottom-line" variant associations for 1,281 complex traits by integrating data across published genome-wide association studies.

A resource of "bottom-line" variant associations for 1,281 complex traits by integrating data across published genome-wide association studies.

Journal: Research square

Published: February 06, 2026

A resource of "bottom-line" variant associations for 1,281 complex traits by integrating data across published genome-wide association studies.

A resource of "bottom-line" variant associations for 1,281 complex traits by integrating data across published genome-wide association studies.

Journal: Research square

Published: February 06, 2026

Identifying druggable proteins of the association of chronotype on breast cancer using Mendelian randomization.

Identifying druggable proteins of the association of chronotype on breast cancer using Mendelian randomization.

Journal: Communications medicine

Published: December 05, 2025

GLP-1 receptor agonists and cardiovascular outcomes in Asian, Black or African American, and White populations: An updated meta-analysis including the SOUL trial.

GLP-1 receptor agonists and cardiovascular outcomes in Asian, Black or African American, and White populations: An updated meta-analysis including the SOUL trial.

Journal: Diabetes, obesity & metabolism

Published: November 17, 2025

Elucidating the proteomic pathways linking childhood body mass index with type 2 diabetes: a Mendelian randomization and recall-by-genotype study.

Elucidating the proteomic pathways linking childhood body mass index with type 2 diabetes: a Mendelian randomization and recall-by-genotype study.

Journal: International journal of epidemiology

Published: November 02, 2025

Toward Data-Driven MODY Panels: Strong Evidence for NEUROD1 and PDX1, Limited Support for APPL1 and WFS1.

Toward Data-Driven MODY Panels: Strong Evidence for NEUROD1 and PDX1, Limited Support for APPL1 and WFS1.

Journal: Diabetes

Published: October 20, 2025

Showing 1-12 of 57

Last Updated: 09/26/2026